Adropin: a hepatokine modulator of vascular function and cardiac fuel metabolism

Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H238-H244. doi: 10.1152/ajpheart.00449.2020. Epub 2020 Nov 20.

Abstract

Adropin is a nutritionally regulated peptide hormone, secreted primarily by the liver, which modulates metabolic homeostasis in a number of tissues. Growing evidence suggests that adropin is an important regulatory component in a number of cardiovascular pathologies, and may be central to the control of cardiac fuel metabolism and vascular function. In this mini-review, we examine the known facets of adropin biology, discuss open questions in the field, and speculate on the therapeutic potential of targeting adropin-related signaling pathways in cardiovascular diseases.

Keywords: adropin; cardiac metabolism; endothelial biology; energy homeostasis; vascular function.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Blood Vessels / drug effects
  • Blood Vessels / metabolism*
  • Blood Vessels / physiopathology
  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism*
  • Cardiovascular Diseases / physiopathology
  • Energy Metabolism* / drug effects
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Intercellular Signaling Peptides and Proteins / therapeutic use
  • Myocardium / metabolism*
  • Signal Transduction

Substances

  • Cardiovascular Agents
  • Enho protein, human
  • Intercellular Signaling Peptides and Proteins